COYA · Categories · Form 4

COYA - SEC Form 4 insider transactions

Coya Therapeutics Inc. (COYA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for COYA

• 62d
  SEC Form 4 filed by Pavao Mark H

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 136d
  SEC Form 4 filed by Chief Financial Officer Snyder David S

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 136d
  SEC Form 4 filed by Chief Executive Officer Swaminathan Arun

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 136d
  SEC Form 4 filed by Chief Medical Officer Grossman Fred

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 136d
  SEC Form 4 filed by Executive Chairman Berman Howard

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 155d
  SEC Form 4 filed by Director Villalobos Anabella

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 155d
  SEC Form 4 filed by Director Goldstein Dov A Md

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 155d
  SEC Form 4 filed by Director Weinand Dieter

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 155d
  SEC Form 4 filed by Director Ross Wilbur L Jr

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 155d
  SEC Form 4 filed by Director Lee Ann

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 295d
  Director Goldstein Dov A Md exercised 17,557 shares at a strike of $1.09, increasing direct ownership by 176% to 27,557 units (SEC Form 4)

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 470d
  SEC Form 4 filed by Director Weinand Dieter

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 470d
  SEC Form 4 filed by Director Ross Wilbur L Jr

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 470d
  SEC Form 4 filed by Director Lee Ann

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 470d
  SEC Form 4 filed by Director Goldstein Dov A Md

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 470d
  SEC Form 4 filed by Director Villalobos Anabella

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 514d
  SEC Form 4 filed by Chief Medical Officer Grossman Fred

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 514d
  SEC Form 4 filed by Chief Executive Officer Swaminathan Arun

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 514d
  SEC Form 4 filed by Director Berman Howard

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 514d
  SEC Form 4 filed by Chief Financial Officer Snyder David S

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 523d
  SEC Form 4 filed by Director Villalobos Anabella

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 523d
  SEC Form 4 filed by Director Goldstein Dov A Md

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 523d
  SEC Form 4 filed by Director Ross Wilbur L Jr

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 523d
  SEC Form 4 filed by Director Lee Ann

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 523d
  SEC Form 4 filed by Director Weinand Dieter

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 735d
  SEC Form 4 filed by Grossman Fred

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 735d
  SEC Form 4 filed by Snyder David S

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 735d
  SEC Form 4 filed by Berman Howard

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)

Other COYA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends